latest news releases from the newsroom
Harwood Feffer LLP
Attention Corinthian Colleges Investors: Wechsler Harwood Sues Nasdaq -- COCO
NEW YORK, Dec. 11, 2003 (PRIMEZONE) -- On December 8, 2003 the law firm of Wechsler Harwood LLP (http://www.whesq.com) filed a class action suit against the Nasdaq Stock Market Inc. ("Nasdaq") and its President and CEO (collectively, the "Defendants") in the United States District Court for the Southern District of New York, 03-CV-09730, on behalf of all persons who traded the stock of Corinthian Colleges, Inc. (Nasdaq:COCO) between 10:46 a.m. and approximately 12:30 p.m. on December 5, 2003 (the "Class Period").
Peabodys Secures Financing And Enters Into Redemption Agreement With Debenture Holder
ROCKLIN, Calif., Dec. 11, 2003 (PRIMEZONE) -- Peabodys Coffee, Inc. (OTCBB:PBDY), a retailer and marketer of the USDA certified organic brand Black Rhino Coffee(tm), announced today that it has entered into a financing agreement with a California-based investment fund. Pursuant to the agreement, the company has issued convertible debt and warrants in a private placement in exchange for an initial investment of $250,000, with provision for an additional $2.5 million if certain terms and condition are met. Peabodys intends to use the proceeds from the financing for general working capital purposes and to prepay certain outstanding liabilities owed to its existing secured debenture holders (the "Debenture Holders").
ProtoKinetix Reaches Agreement On Research To Deliver Catalytic Antibody
VANCOUVER, British Columbia, Canada, Dec. 11, 2003 (PRIMEZONE) -- Dr. John Todd, president of ProtoKinetix, Inc.(OTCBB:PKTX), announces today that the company has signed a Letter of Intent with Perigene Inc., whereby Perigene has been contracted to conduct the research to develop a catalytic antibody against the RECAF receptor site. Perigene acquired the world wide rights to the abzyme technology from France's University of Compiegne, headed up by Dr. Daniel Thomas. Dr. Thomas is a world recognized leader in advanced antibody development.
ADVA Optical Networking
ADVA Optical Networking Successfully Demonstrates A Next-Generation Global Seamless Network Solution For Deutsche Telekom
MUNICH, Germany, and MAHWAH, N.J., Dec. 11, 2003 (PRIMEZONE) -- ADVA Optical Networking (FSE:ADV), a leading global provider of optical networking solutions, today announced that it has successfully demonstrated a live network showcase as part of Deutsche Telekom's Global Seamless Network (GSN) Project in Darmstadt and Berlin, Germany. The GSN Project culminates months of extensive research by Deutsche Telekom into next-generation network technologies and applications, and careful selection of several participating vendors, including ADVA Optical Networking and Extreme Networks. The effort was launched by the carrier's vision for a worldwide telecommunications network managed by a single network management platform with the necessary operations and service deployment functionality.
Convertibles program to employees of WM-data Aktiebolag (publ) fully subscribed
STOCKHOLM, Sweden, Dec. 11, 2003 (PRIMEZONE) -- In the convertibles program for WM-data's employees, which was decided at an Extraordinary General Meeting held on November 4, 2003, 1,364 persons with subscription entitlement subscribed for convertibles amounting to about SEK 215 M. After reduction, the loan was set at approximately SEK 207 M. The conversion price is SEK 21. At full conversion, share capital will increase by SEK 9,846,298, corresponding to dilution of about 2.6 percent of share capital and approximately 1.5 percent of the number of votes.